Gentian Diagnostics ASA has appointed Dr. Aleksandra Havelka as its new Chief Scientific Officer (CSO). Dr Havelka comes from the role as VP Science and Clinical Affairs at Gentian Diagnostics and was previously Biochemist and Unit Manager at Karolinska University Laboratory with research focusing on biomarkers for inflammation and infection. Dr. Erling Sundrehagen (71), who co-founded Gentian in 2001 and has held the CSO role since 2019, is moving into a new role as Consulting Founder and will initially devote his time to the development of NT-proBNP.

In 2022, Gentian strengthened its R&D team which now consists of Dr Torsten Knüttel (VP R&D), Dr Tom Nilsen (Head of Product Development) and Dr Ingo Curdt (Head of Innovation and Research) who joined the company earlier this year. The announced changes will take effect from 1 January 2023.